Vaxart, Inc.
VXRT· OTC
VXRTVaxart, Inc.
Filed Sep 30, 2014 · 10-K · 92 days after period end · 0001437749-14-017648
| Metric | Q4 2014 | Q4 2013 | Q4 2011 | Q4 2010dderived from reported figures |
|---|---|---|---|---|
| Revenue | $8.50M | $9.30M | $2.09M | — |
| Net Income | -$10.20M | -$6.50M | -$7.06M | — |
| EPS Diluted | -$0.29 | -$0.23 | -$0.31 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vaxart, Inc. · CIK 72444 · Engraved from SEC EDGAR
ended Jun 30, 2014 · filed Sep 30, 2014 · 92 d after period end
